One Health approach to Rift Valley fever vaccine development

Antiviral Research

Volumn 106, Issue 1, 2014, Pages 24-32

  Kortekaas, Jeroen ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Human; One Health; Rift Valley fever virus; Vaccine; Veterinary

Indexed keywords

CONE 13 VACCINE; DNA VACCINE; LIVE VACCINE; MP 12 VACCINE; RIFT VALLEY FEVER VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE; INACTIVATED VACCINE; SUBUNIT VACCINE; VIRUS VECTOR;

CLINICAL FEATURE; DRUG EFFICACY; DRUG SAFETY; HUMAN; LICENSING; NONHUMAN; PRIMATE MODEL; PRIORITY JOURNAL; REPLICON; REVIEW; RIFT VALLEY FEVER; VACCINATION; EPIDEMIC; RIFT VALLEY FEVER BUNYAVIRUS; VETERINARY MEDICINE; VIRUS TRANSMISSION; ANIMAL; DRUG APPROVAL; DRUG DEVELOPMENT; IMMUNOLOGY; ISOLATION AND PURIFICATION; LIVESTOCK; PROCEDURES; RIFT VALLEY FEVER VIRUS;

ANIMALS; DRUG APPROVAL; DRUG DISCOVERY; HUMANS; LIVESTOCK; RIFT VALLEY FEVER; RIFT VALLEY FEVER VIRUS; VIRAL VACCINES;

EID: 84898731453     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2014.03.008     Document Type: Review

References (108)

1. M. Al-Hazmi, E.A. Ayoola, M. Abdurahman, S. Banzal, J. Ashraf, A. El-Bushra, A. Hazmi, M. Abdullah, H. Abbo, A. Elamin, T. Al-Sammani el, M. Gadour, C. Menon, M. Hamza, I. Rahim, M. Hafez, M. Jambavalikar, H. Arishi, and A. Aqeel Epidemic Rift Valley fever in Saudi Arabia: a clinical study of severe illness in humans Clin. Infect. Dis. 36 2003 245 252 (Pubitemid 36169657)
2. S.F. Andriamandimby, A.E. Randrianarivo-Solofoniaina, E.M. Jeanmaire, L. Ravololomanana, L.T. Razafimanantsoa, T. Rakotojoelinandrasana, J. Razainirina, J. Hoffmann, J.P. Ravalohery, J.T. Rafisandratantsoa, P.E. Rollin, and J.M. Reynes Rift Valley fever during rainy seasons, Madagascar, 2008 and 2009 Emerg. Infect. Dis. 16 2010 963 970
3. A. Anyamba, K.J. Linthicum, J. Small, S.C. Britch, E. Pak, S. de La Rocque, P. Formenty, A.W. Hightower, R.F. Breiman, J.P. Chretien, C.J. Tucker, D. Schnabel, R. Sang, K. Haagsma, M. Latham, H.B. Lewandowski, S.O. Magdi, M.A. Mohamed, P.M. Nguku, J.M. Reynes, and R. Swanepoel Prediction, assessment of the Rift Valley fever activity in East and Southern Africa 2006-2008 and possible vector control strategies Am. J. Trop. Med. Hyg. 83 2010 43 51
4. I.E. Aradaib, B.R. Erickson, R.M. Elageb, M.L. Khristova, S.A. Carroll, I.M. Elkhidir, M.E. Karsany, A.E. Karrar, M.I. Elbashir, and S.T. Nichol Rift Valley fever, Sudan, 2007 and 2010 Emerg. Infect. Dis. 19 2013 246 253
5. B.N. Archer, J. Weyer, J. Paweska, D. Nkosi, P. Leman, K.S. Tint, and L. Blumberg Outbreak of Rift Valley fever affecting veterinarians and farmers in South Africa, 2008 S. Afr. Med. J. 101 2011 263 266
6. N. Bhardwaj, M.T. Heise, and T.M. Ross Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus PLoS Neglected Trop. Dis. 4 2010 e725
7. L.N. Binn, R. Randall, V.R. Harrison, C.J. Gibbs Jr., and C.G. Aulisio Immunization against Rift Valley fever. The development of vaccines from nonprimate cell cultures and chick embryos Am. J. Hyg. 77 1963 160 168
8. B.H. Bird, C.G. Albarino, A.L. Hartman, B.R. Erickson, T.G. Ksiazek, and S.T. Nichol Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals J. Virol. 82 2008 2681 2691 (Pubitemid 351329159)
9. B.H. Bird, C.G. Albarino, and S.T. Nichol Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease Virology 362 2007 10 15 (Pubitemid 46617699)
10. B.H. Bird, L.H. Maartens, S. Campbell, B.J. Erasmus, B.R. Erickson, K.A. Dodd, C.F. Spiropoulou, D. Cannon, C.P. Drew, B. Knust, A.K. McElroy, M.L. Khristova, C.G. Albarino, and S.T. Nichol Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep J. Virol. 85 2011 12901 12909
11. B.H. Bird, and S.T. Nichol Breaking the chain: Rift Valley fever virus control via livestock vaccination Curr. Opin. Virol. 2 2012 315 323
12. H. Boshra, G. Lorenzo, F. Rodriguez, and A. Brun A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(-/-) mice upon lethal virus challenge Vaccine 29 2011 4469 4475
13. M. Bouloy, and R. Flick Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines Antiviral Res. 84 2009 101 118
14. B. Brennan, S.R. Welch, A. McLees, and R.M. Elliott Creation of a recombinant Rift Valley fever virus with a two-segmented genome J. Virol. 85 2011 10310 10318
15. A. Bukreyev, and P.L. Collins Newcastle disease virus as a vaccine vector for humans Curr. Opin. Mol. Ther. 10 2008 46 55 (Pubitemid 351170594)
16. H. Caplen, C.J. Peters, and D.H. Bishop Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development J. Gen. Virol. 66 Pt. 10 1985 2271 2277 (Pubitemid 15250309)
17. CDC, 1998. Rift Valley Fever - East Africa, 1997-1998. MMWR. Morbidity and mortality weekly report 47, pp. 261-4.
18. CDC, 2000a. Outbreak of Rift Valley fever - Saudi Arabia, August-October, 2000. MMWR. Morbidity and mortality weekly report 49, pp. 905-908.
19. CDC, 2000b. Outbreak of Rift Valley fever - Yemen, August-October 2000. MMWR. Morbidity and mortality weekly report 49, pp. 1065, 1066.
20. CDC, 2000c. Update: outbreak of Rift Valley Fever - Saudi Arabia, August-November 2000. MMWR. Morbidity and mortality weekly report 49, pp. 982-985.
21. R. Daubney Rift Valley fever Lancet 218 1931 1367 1368
22. R. Daubney, J.R. Hudson, and P.C. Garnham Enzootic hepatitis or rift valley fever. An undescribed virus disease of sheep cattle and man from East Africa J. Pathol. Bacteriol. 34 1931 545 579
23. R. Daubney, J.R. Hudson, and P.C. Garnham Enzootic hepatitis or Rift Valley fever: an undescribed disease of sheep, cattle and man from East Africa J. Pathol. Bacteriol. 34 1931 545 579
24. S.M. de Boer, J. Kortekaas, A.F. Antonis, J. Kant, J.L. van Oploo, P.J. Rottier, R.J. Moormann, and B.J. Bosch Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge Vaccine 28 2010 2330 2339
25. K.A. Dodd, B.H. Bird, M.G. Metcalfe, S.T. Nichol, and C.G. Albarino Single-dose immunization with virus replicon particles confers rapid robust protection against Rift Valley fever virus challenge J. Virol. 86 2012 4204 4212
26. B. Dungu, I. Louw, A. Lubisi, P. Hunter, B.F. von Teichman, and M. Bouloy Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep Vaccine 28 2010 4581 4587
27. A.B. El Mamy, M.O. Baba, Y. Barry, K. Isselmou, M.L. Dia, M.O. El Kory, M. Diop, M.M. Lo, Y. Thiongane, M. Bengoumi, L. Puech, L. Plee, F. Claes, S. de La Rocque, and B. Doumbia Unexpected Rift Valley fever outbreak, northern Mauritania Emerg. Infect. Dis. 17 2011 1894 1896
28. FDA, 2013. Approval of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible Code of Federal Regulations.
29. G.M. Findlay Rift Valley fever or enzootic hepatitis Trans. R. Soc. Trop. Med. Hyg. 25 1932 229 265
30. G.M. Findlay, and R. Daubney The virus of Rift Valley fever or enzootic hepatitis Lancet 221 1931 1350 1351
31. I. Freed Rift valley fever in man, complicated by retinal changes and loss of vision S. Afr. Med. J. 25 1951 930 932
32. J. Gear, B. De Meillon, V. Measroch, D.H. Davis, and H. Harwin Rift valley fever in South Africa. 2. The occurrence of human cases in the Orange Free State, the North-Western Cape Province, the Western and Southern Transvaal. B. Field and Laboratory Investigation S. Afr. Med. J. 25 1951 908 912
33. S.R. Gerrard, B.H. Bird, C.G. Albarino, and S.T. Nichol The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection Virology 359 2007 459 465 (Pubitemid 46274872)
34. R. Gorchakov, E. Volkova, N. Yun, O. Petrakova, N.S. Linde, S. Paessler, E. Frolova, and I. Frolov Comparative analysis of the alphavirus-based vectors expressing Rift Valley fever virus glycoproteins Virology 366 2007 212 225 (Pubitemid 47314401)
35. A.L. Hartman, D.S. Powell, L.M. Bethel, A.L. Caroline, R.J. Schmid, T. Oury, and D.S. Reed Aerosolized Rift Valley Fever virus causes fatal encephalitis in African green monkeys and common marmosets J. Virol. 88 2014 2235 2245
36. O.A. Hassan, C. Ahlm, R. Sang, and M. Evander The 2007 Rift Valley fever outbreak in Sudan PLoS Neglected Trop. Dis. 5 2011 e1229
37. M.T. Heise, A. Whitmore, J. Thompson, M. Parsons, A.A. Grobbelaar, A. Kemp, J.T. Paweska, K. Madric, L.J. White, R. Swanepoel, and F.J. Burt An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus Epidemiol. Infect. 137 2009 1309 1318
38. D.H. Holman, A. Penn-Nicholson, D. Wang, J. Woraratanadharm, M.K. Harr, M. Luo, E.M. Maher, M.R. Holbrook, and J.Y. Dong A complex adenovirus-vectored vaccine against Rift Valley fever virus protects mice against lethal infection in the presence of preexisting vector immunity Clin. Vaccine Immunol. 16 2009 1624 1632
39. H. Hoogstraal, J.M. Meegan, G.M. Khalil, and F.K. Adham The Rift Valley fever epizootic in Egypt 1977-78. 2. Ecological and entomological studies Trans. R. Soc. Trop. Med. Hyg. 73 1979 624 629 (Pubitemid 10158922)
40. P. Hunter, B.J. Erasmus, and J.H. Vorster Teratogenicity of a mutagenised Rift Valley fever virus (MVP 12) in sheep Onderstepoort J. Vet. Res. 69 2002 95 98 (Pubitemid 34983797)
41. A. Jouan, I. Coulibaly, F. Adam, B. Philippe, O. Riou, B. Leguenno, R. Christie, N. Ould Merzoug, T. Ksiazek, and J.P. Digoutte Analytical study of a Rift Valley fever epidemic Res. Virol. 140 1989 175 186 (Pubitemid 19116166)
42. A. Jouan, B. Le Guenno, J.P. Digoutte, B. Philippe, O. Riou, and F. Adam An RVF epidemic in southern Mauritania. Annales de l'Institut Pasteur Virology 139 1988 307 308
43. J.D. Joubert, A.L. Ferguson, and J. Gear Rift Valley fever in South Africa: 2. The occurrence of human cases in the Orange Free State, the north-western Cape province, the western and southern Transvaal. A epidemiological and clinical findings S. Afr. Med. J. 25 1951 890 891
44. P.G. Jupp, A. Kemp, A. Grobbelaar, P. Lema, F.J. Burt, A.M. Alahmed, D. Al Mujalli, M. Al Khamees, and R. Swanepoel The 2000 epidemic of Rift Valley fever in Saudi Arabia: mosquito vector studies Med. Vet. Entomol. 16 2002 245 252
45. L.T. Kakach, J.A. Suzich, and M.S. Collett Rift Valley fever virus M segment: phlebovirus expression strategy and protein glycosylation Virology 170 1989 505 510 (Pubitemid 19162564)
46. L.T. Kakach, T.L. Wasmoen, and M.S. Collett Rift Valley fever virus M segment: use of recombinant vaccinia viruses to study Phlebovirus gene expression J. Virol. 62 1988 826 833 (Pubitemid 18068639)
47. J.D. Kark, Y. Aynor, and C.J. Peters A Rift Valley fever vaccine trial. I. Side effects and serologic response over a six-month follow-up Am. J. Epidemiol. 116 1982 808 820 (Pubitemid 13244205)
48. J.D. Kark, Y. Aynor, and C.J. Peters A Rift Valley fever vaccine trial: 2. Serological response to booster doses with a comparison of intradermal versus subcutaneous injection Vaccine 3 1985 117 122 (Pubitemid 15026713)
49. S.F. Kitchen Laboratory infections with the virus of Rift Valley fever Am. J. Trop. Med. 14 1934 547 564
50. J. Kortekaas, A.F. Antonis, J. Kant, R.P. Vloet, A. Vogel, N. Oreshkova, S.M. de Boer, B.J. Bosch, and R.J. Moormann Efficacy of three candidate Rift Valley fever vaccines in sheep Vaccine 30 2012 3423 3429
51. J. Kortekaas, S.M. de Boer, J. Kant, R.P. Vloet, A.F. Antonis, and R.J. Moormann Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector Vaccine 28 2010 4394 4401
52. J. Kortekaas, N. Oreshkova, V. Cobos-Jimenez, R.P. Vloet, C.A. Potgieter, and R.J. Moormann Creation of a nonspreading Rift Valley fever virus J. Virol. 85 2011 12622 12630
53. J. Kortekaas, J. Zingeser, P. de Leeuw, S. de La Rocque, H. Unger, and R.J. Moormann Rift Valley fever vaccine development, progress and constraints Emerg. Infect. Dis. 17 2011 e1
54. R. Koukuntla, R.B. Mandell, and R. Flick Virus-like particle-based countermeasures against Rift Valley fever virus Zoonoses Public Health 59 Suppl. 2 2012 142 150
55. A.D. LaBeaud, S. Muiruri, L.J. Sutherland, S. Dahir, G. Gildengorin, J. Morrill, E.M. Muchiri, C.J. Peters, and C.H. King Postepidemic analysis of Rift Valley fever virus transmission in northeastern kenya: a village cohort study PLoS Neglected Trop. Dis. 5 2011 e1265
56. N. Lagerqvist, J. Naslund, A. Lundkvist, M. Bouloy, C. Ahlm, and G. Bucht Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs Virol. J. 6 2009 6
57. L. Li, F. Saade, and N. Petrovsky The future of human DNA vaccines J. Biotechnol. 162 2012 171 182
58. E. Lopez-Gil, G. Lorenzo, E. Hevia, B. Borrego, M. Eiden, M. Groschup, S.C. Gilbert, and A. Brun A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection PLoS Neglected Trop. Dis. 7 2013 e2309
59. G. Lorenzo, R. Martin-Folgar, E. Hevia, H. Boshra, and A. Brun Protection against lethal Rift Valley fever virus (RVFV) infection in transgenic IFNAR(-/-) mice induced by different DNA vaccination regimens Vaccine 28 2010 2937 2944
60. G. Lorenzo, R. Martin-Folgar, F. Rodriguez, and A. Brun Priming with DNA plasmids encoding the nucleocapsid protein and glycoprotein precursors from Rift Valley fever virus accelerates the immune responses induced by an attenuated vaccine in sheep Vaccine 26 2008 5255 5262
61. T.A. Madani, Y.Y. Al-Mazrou, M.H. Al-Jeffri, A.A. Mishkhas, A.M. Al-Rabeah, A.M. Turkistani, M.O. Al-Sayed, A.A. Abodahish, A.S. Khan, T.G. Ksiazek, and O. Shobokshi Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics Clin. Infect. Dis. 37 2003 1084 1092 (Pubitemid 37323663)
62. R.B. Mandell, R. Koukuntla, L.J. Mogler, A.K. Carzoli, A.N. Freiberg, M.R. Holbrook, B.K. Martin, W.R. Staplin, N.N. Vahanian, C.J. Link, and R. Flick A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge Virology 397 2010 187 198
63. R.B. Mandell, R. Koukuntla, L.J. Mogler, A.K. Carzoli, M.R. Holbrook, B.K. Martin, N. Vahanian, C.J. Link, and R. Flick Novel suspension cell-based vaccine production systems for Rift Valley fever virus-like particles J. Virol. Methods 169 2010 259 268
64. B.M. McIntosh, D. Russell, I. dos Santos, and J.H. Gear Rift Valley fever in humans in South Africa S. Afr. Med. J. 58 1980 803 806 (Pubitemid 11252892)
65. J.M. Meegan The Rift Valley fever epizootic in Egypt 1977-78. 1. Description of the epizootic and virological studies Trans. R. Soc. Trop. Med. Hyg. 73 1979 618 623 (Pubitemid 10158921)
66. J.M. Meegan, H. Hoogstraal, and M.I. Moussa An epizootic of Rift Valley fever in Egypt in 1977 Vet. Rec. 105 1979 124 125
67. J.M. Meegan, G.M. Khalil, H. Hoogstraal, and F.K. Adham Experimental transmission and field isolation studies implicating Culex pipiens as a vector of Rift Valley fever virus in Egypt Am. J. Trop. Med. Hyg. 29 1980 1405 1410 (Pubitemid 11212974)
68. B.R. Miller, M.S. Godsey, M.B. Crabtree, H.M. Savage, Y. Al-Mazrao, M.H. Al-Jeffri, A.M. Abdoon, S.M. Al-Seghayer, A.M. Al-Shahrani, and T.G. Ksiazek Isolation and genetic characterization of Rift Valley fever virus from Aedes vexans arabiensis, Kingdom of Saudi Arabia Emerg. Infect. Dis. 8 2002 1492 1494 (Pubitemid 36008790)
69. M. Mohamed, F. Mosha, J. Mghamba, S.R. Zaki, W.J. Shieh, J. Paweska, S. Omulo, S. Gikundi, P. Mmbuji, P. Bloland, N. Zeidner, R. Kalinga, R.F. Breiman, and M.K. Njenga Epidemiologic and clinical aspects of a Rift Valley fever outbreak in humans in Tanzania, 2007 Am. J. Trop. Med. Hyg. 83 2010 22 27
70. J.C. Morrill, L. Carpenter, D. Taylor, H.H. Ramsburg, J. Quance, and C.J. Peters Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep Vaccine 9 1991 35 41
71. J.C. Morrill, G.B. Jennings, H. Caplen, M.J. Turell, A.J. Johnson, and C.J. Peters Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes Am. J. Vet. Res. 48 1987 1042 1047
72. J.C. Morrill, R.C. Laughlin, N. Lokugamage, R. Pugh, E. Sbrana, W.J. Weise, L.G. Adams, S. Makino, and C.J. Peters Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep Vaccine 31 2013 559 565
73. J.C. Morrill, C.A. Mebus, and C.J. Peters Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle Am. J. Vet. Res. 58 1997 1104 1109 (Pubitemid 27435458)
74. J.C. Morrill, C.A. Mebus, and C.J. Peters Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids Am. J. Vet. Res. 58 1997 1110 1114 (Pubitemid 27435459)
75. J.C. Morrill, and C.J. Peters Pathogenicity and neurovirulence of a mutagen-attenuated Rift Valley fever vaccine in rhesus monkeys Vaccine 21 2003 2994 3002 (Pubitemid 36703208)
76. J.C. Morrill, and C.J. Peters Mucosal immunization of rhesus macaques with Rift Valley Fever MP-12 vaccine J. Infect. Dis. 204 2011 617 625
77. J.C. Morrill, and C.J. Peters Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent rift valley fever virus J. Infect. Dis. 204 2011 229 236
78. R. Muller, J.F. Saluzzo, N. Lopez, T. Dreier, M. Turell, J. Smith, and M. Bouloy Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment Am. J. Trop. Med. Hyg. 53 1995 405 411
79. B. Mundel, and J. Gear Rift valley fever; I. The occurrence of human cases in Johannesburg S. Afr. Med. J. 25 1951 797 800
80. P. Nabeth, Y. Kane, M.O. Abdalahi, M. Diallo, K. Ndiaye, K. Ba, F. Schneegans, A.A. Sall, and C. Mathiot Rift Valley fever outbreak, Mauritania, 1998: seroepidemiologic, virologic, entomologic, and zoologic investigations Emerg. Infect. Dis. 7 2001 1052 1054 (Pubitemid 33115794)
81. N. Oreshkova, L. Keulen, J. Kant, R.J.M. Moormann, and J. Kortekaas A single vaccination with an improved nonspreading Rift Valley fever virus vaccine provides sterile immunity in lambs PLoS One 8 2013 e77461
82. J.F. Papin, P.H. Verardi, L.A. Jones, F. Monge-Navarro, A.C. Brault, M.R. Holbrook, M.N. Worthy, A.N. Freiberg, and T.D. Yilma Recombinant Rift Valley fever vaccines induce protective levels of antibody in baboons and resistance to lethal challenge in mice Proc. Natl. Acad. Sci. U.S.A. 108 2011 14926 14931
83. C.J. Peters, D. Jones, R. Trotter, J. Donaldson, J. White, E. Stephen, and T.W. Slone Jr. Experimental Rift Valley fever in rhesus macaques Arch. Virol. 99 1988 31 44
84. C.J. Peters, and K.J. Linthicum Rift Valley Fever, Handbook of Zoonoses 1994 CRC Press Boca Raton, FL pp. 25-138
85. C.J. Peters, P.R. Pittman, and J.C. Morrill Genetic and Clinical Evaluation of MP-12: A Live Attenuated Vaccine for Rift Valley Fever Virus (RVFV) 2008 Vaccine 2nd Global Congress Boston, MA
86. R. Randall, L.N. Binn, and V.R. Harrison Immunization against Rift Valley fever virus. Studies on the immunogenicity of lyophilized formalin-inactivated vaccine J. Immunol. 93 1964 293 299
87. R. Randall, C.J. Gibbs Jr., C.G. Aulisio, L.N. Binn, and V.R. Harrison The development of a formalin-killed Rift Valley fever virus vaccine for use in man J. Immunol. 89 1962 660 671
88. J.M. Rusnak, P. Gibbs, E. Boudreau, D.P. Clizbe, and P. Pittman Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study Vaccine 29 2011 3222 3229
89. J.F. Saluzzo, and J.F. Smith Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine Vaccine 8 1990 369 375 (Pubitemid 20264815)
90. C.S. Schmaljohn, M.D. Parker, W.H. Ennis, J.M. Dalrymple, M.S. Collett, J.A. Suzich, and A.L. Schmaljohn Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins Virology 170 1989 184 192 (Pubitemid 19133974)
91. L. Schrire Macular changes in rift valley fever S. Afr. Med. J. 25 1951 926 930
92. Schulz, K.H., 1951. Rift Valley fever in South Africa, Special Report No. 5/51 Union Department of Health, Plague Research Laboratory, pp. 1-26.
93. F.F. Schwentker, and T.M. Rivers Rift Valley fever in man: report of a fatal laboratory infection complicated by thrombophlebitis J. Exp. Med. 59 1934 305 313
94. D.R. Smith, B.H. Bird, B. Lewis, S.C. Johnston, S. McCarthy, A. Keeney, M. Botto, G. Donnelly, J. Shamblin, C.G. Albarino, S.T. Nichol, and L.E. Hensley Development of a novel nonhuman primate model for Rift Valley fever J. Virol. 86 2012 2109 2120
95. K.C. Smithburn, A.J. Haddow, and J.D. Gillett Rift Valley fever; isolation of the virus from wild mosquitoes Br. J. Exp. Pathol. 29 1948 107 121
96. K.C. Smithburn, and A.F. Mahaffy et al. Rift Valley fever; accidental infections among laboratory workers J. Immunol. 62 1949 213 227
97. K. Spik, A. Shurtleff, A.K. McElroy, M.C. Guttieri, J.W. Hooper, and C. SchmalJohn Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus Vaccine 24 2006 4657 4666 (Pubitemid 43776769)
98. D.J. van Velden, J.D. Meyer, J. Olivier, J.H. Gear, and B. McIntosh Rift Valley fever affecting humans in South Africa: a clinicopathological study S. Afr. Med. J. 51 1977 867 871 (Pubitemid 8135309)
99. P. Vialat, A. Billecocq, A. Kohl, and M. Bouloy The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice J. Virol. 74 2000 1538 1543 (Pubitemid 30044105)
100. P. Vialat, R. Muller, T.H. Vu, C. Prehaud, and M. Bouloy Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation Virus Res. 52 1997 43 50 (Pubitemid 28011276)
101. B. von Teichman, A. Engelbrecht, G. Zulu, B. Dungu, A. Pardini, and M. Bouloy Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves Vaccine 29 2011 5771 5777
102. D.B. Wallace, C.E. Ellis, A. Espach, S.J. Smith, R.R. Greyling, and G.J. Viljoen Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever Vaccine 24 2006 7181 7189 (Pubitemid 46107193)
103. G.M. Warimwe, G. Lorenzo, E. Lopez-Gil, A. Reyes-Sandoval, M.G. Cottingham, A.J. Spencer, K.A. Collins, M.D. Dicks, A. Milicic, A. Lall, J. Furze, A.V. Turner, A.V. Hill, A. Brun, and S.C. Gilbert Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice Virol. J. 10 2013 349
104. H.M. Weingartl, C.K. Nfon, S. Zhang, P. Marszal, W.C. Wilson, J.C. Morrill, G.E. Bettinger, and C.J. Peters Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep Vaccine 2014
105. WHO, 2000. Outbreak of Rift Valley fever, Yemen, August-October 2000. Releve epidemiologique hebdomadaire/Section d'hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record/Health Section of the Secretariat of the League of Nations 75, pp. 392-395.
106. WHO, 2010. Rift Valley fever, South Africa - update. Releve epidemiologique hebdomadaire/Section d'hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record/Health Section of the Secretariat of the League of Nations 85, pp. 185, 186.
107. WHO, 2012. Outbreak news. Rift Valley fever, Mauritania. Releve epidemiologique hebdomadaire/Section d'hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record/Health Section of the Secretariat of the League of Nations 87, p. 438.
108. C.W. Woods, A.M. Karpati, T. Grein, N. McCarthy, P. Gaturuku, E. Muchiri, L. Dunster, A. Henderson, A.S. Khan, R. Swanepoel, I. Bonmarin, L. Martin, P. Mann, B.L. Smoak, M. Ryan, T.G. Ksiazek, R.R. Arthur, A. Ndikuyeze, N.N. Agata, and C.J. Peters An outbreak of Rift Valley fever in Northeastern Kenya, 1997-98 Emerg. Infect. Dis. 8 2002 138 144 (Pubitemid 34202435)